471 related articles for article (PubMed ID: 27552585)
1. Oxytocin efficacy is modulated by dosage and oxytocin receptor genotype in young adults with high-functioning autism: a 24-week randomized clinical trial.
Kosaka H; Okamoto Y; Munesue T; Yamasue H; Inohara K; Fujioka T; Anme T; Orisaka M; Ishitobi M; Jung M; Fujisawa TX; Tanaka S; Arai S; Asano M; Saito DN; Sadato N; Tomoda A; Omori M; Sato M; Okazawa H; Higashida H; Wada Y
Transl Psychiatry; 2016 Aug; 6(8):e872. PubMed ID: 27552585
[TBL] [Abstract][Full Text] [Related]
2. Effects of multiple-dose intranasal oxytocin administration on social responsiveness in children with autism: a randomized, placebo-controlled trial.
Daniels N; Moerkerke M; Steyaert J; Bamps A; Debbaut E; Prinsen J; Tang T; Van der Donck S; Boets B; Alaerts K
Mol Autism; 2023 Apr; 14(1):16. PubMed ID: 37081454
[TBL] [Abstract][Full Text] [Related]
3. Clinical and neural effects of six-week administration of oxytocin on core symptoms of autism.
Watanabe T; Kuroda M; Kuwabara H; Aoki Y; Iwashiro N; Tatsunobu N; Takao H; Nippashi Y; Kawakubo Y; Kunimatsu A; Kasai K; Yamasue H
Brain; 2015 Nov; 138(Pt 11):3400-12. PubMed ID: 26336909
[TBL] [Abstract][Full Text] [Related]
4. Oxytocin receptor gene variations predict neural and behavioral response to oxytocin in autism.
Watanabe T; Otowa T; Abe O; Kuwabara H; Aoki Y; Natsubori T; Takao H; Kakiuchi C; Kondo K; Ikeda M; Iwata N; Kasai K; Sasaki T; Yamasue H
Soc Cogn Affect Neurosci; 2017 Mar; 12(3):496-506. PubMed ID: 27798253
[TBL] [Abstract][Full Text] [Related]
5. Dose-dependent social-cognitive effects of intranasal oxytocin delivered with novel Breath Powered device in adults with autism spectrum disorder: a randomized placebo-controlled double-blind crossover trial.
Quintana DS; Westlye LT; Hope S; Nærland T; Elvsåshagen T; Dørum E; Rustan Ø; Valstad M; Rezvaya L; Lishaugen H; Stensønes E; Yaqub S; Smerud KT; Mahmoud RA; Djupesland PG; Andreassen OA
Transl Psychiatry; 2017 May; 7(5):e1136. PubMed ID: 28534875
[TBL] [Abstract][Full Text] [Related]
6. Oxytocin-induced increase in N,N-dimethylglycine and time course of changes in oxytocin efficacy for autism social core symptoms.
Kato Y; Kuwabara H; Okada T; Munesue T; Benner S; Kuroda M; Kojima M; Yassin W; Eriguchi Y; Kameno Y; Murayama C; Nishimura T; Tsuchiya K; Kasai K; Ozaki N; Kosaka H; Yamasue H
Mol Autism; 2021 Feb; 12(1):15. PubMed ID: 33622389
[TBL] [Abstract][Full Text] [Related]
7. The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial.
Yatawara CJ; Einfeld SL; Hickie IB; Davenport TA; Guastella AJ
Mol Psychiatry; 2016 Sep; 21(9):1225-31. PubMed ID: 26503762
[TBL] [Abstract][Full Text] [Related]
8. Randomized clinical trial shows no substantial modulation of empathy-related neural activation by intranasal oxytocin in autism.
Mayer AV; Wermter AK; Stroth S; Alter P; Haberhausen M; Stehr T; Paulus FM; Krach S; Kamp-Becker I
Sci Rep; 2021 Jul; 11(1):15056. PubMed ID: 34301983
[TBL] [Abstract][Full Text] [Related]
9. Effect of a novel nasal oxytocin spray with enhanced bioavailability on autism: a randomized trial.
Yamasue H; Kojima M; Kuwabara H; Kuroda M; Matsumoto K; Kanai C; Inada N; Owada K; Ochi K; Ono N; Benner S; Wakuda T; Kameno Y; Inoue J; Harada T; Tsuchiya K; Umemura K; Yamauchi A; Ogawa N; Kushima I; Ozaki N; Suyama S; Saito T; Uemura Y; Hamada J; Kano Y; Honda N; Kikuchi S; Seto M; Tomita H; Miyoshi N; Matsumoto M; Kawaguchi Y; Kanai K; Ikeda M; Nakamura I; Isomura S; Hirano Y; Onitsuka T; Kosaka H; Okada T
Brain; 2022 Apr; 145(2):490-499. PubMed ID: 35067719
[TBL] [Abstract][Full Text] [Related]
10. Effect of intranasal oxytocin on the core social symptoms of autism spectrum disorder: a randomized clinical trial.
Yamasue H; Okada T; Munesue T; Kuroda M; Fujioka T; Uno Y; Matsumoto K; Kuwabara H; Mori D; Okamoto Y; Yoshimura Y; Kawakubo Y; Arioka Y; Kojima M; Yuhi T; Owada K; Yassin W; Kushima I; Benner S; Ogawa N; Eriguchi Y; Kawano N; Uemura Y; Yamamoto M; Kano Y; Kasai K; Higashida H; Ozaki N; Kosaka H
Mol Psychiatry; 2020 Aug; 25(8):1849-1858. PubMed ID: 29955161
[TBL] [Abstract][Full Text] [Related]
11. The association of single-nucleotide polymorphisms in the oxytocin receptor and G protein-coupled receptor kinase 6 (GRK6) genes with oxytocin dosing requirements and labor outcomes.
Grotegut CA; Ngan E; Garrett ME; Miranda ML; Ashley-Koch AE; Swamy GK
Am J Obstet Gynecol; 2017 Sep; 217(3):367.e1-367.e9. PubMed ID: 28526450
[TBL] [Abstract][Full Text] [Related]
12. Quantitative facial expression analysis revealed the efficacy and time course of oxytocin in autism.
Owada K; Okada T; Munesue T; Kuroda M; Fujioka T; Uno Y; Matsumoto K; Kuwabara H; Mori D; Okamoto Y; Yoshimura Y; Kawakubo Y; Arioka Y; Kojima M; Yuhi T; Yassin W; Kushima I; Benner S; Ogawa N; Kawano N; Eriguchi Y; Uemura Y; Yamamoto M; Kano Y; Kasai K; Higashida H; Ozaki N; Kosaka H; Yamasue H
Brain; 2019 Jul; 142(7):2127-2136. PubMed ID: 31096266
[TBL] [Abstract][Full Text] [Related]
13. The effect of oxytocin nasal spray on social interaction in young children with autism: a randomized clinical trial.
Guastella AJ; Boulton KA; Whitehouse AJO; Song YJ; Thapa R; Gregory SG; Pokorski I; Granich J; DeMayo MM; Ambarchi Z; Wray J; Thomas EE; Hickie IB
Mol Psychiatry; 2023 Feb; 28(2):834-842. PubMed ID: 36302965
[TBL] [Abstract][Full Text] [Related]
14. Behavioral effects of multiple-dose oxytocin treatment in autism: a randomized, placebo-controlled trial with long-term follow-up.
Bernaerts S; Boets B; Bosmans G; Steyaert J; Alaerts K
Mol Autism; 2020; 11(1):6. PubMed ID: 31969977
[TBL] [Abstract][Full Text] [Related]
15. Chronic oxytocin administration stimulates the oxytocinergic system in children with autism.
Moerkerke M; Daniels N; Tibermont L; Tang T; Evenepoel M; Van der Donck S; Debbaut E; Prinsen J; Chubar V; Claes S; Vanaudenaerde B; Willems L; Steyaert J; Boets B; Alaerts K
Nat Commun; 2024 Jan; 15(1):58. PubMed ID: 38167302
[TBL] [Abstract][Full Text] [Related]
16. The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial.
Guastella AJ; Gray KM; Rinehart NJ; Alvares GA; Tonge BJ; Hickie IB; Keating CM; Cacciotti-Saija C; Einfeld SL
J Child Psychol Psychiatry; 2015 Apr; 56(4):444-52. PubMed ID: 25087908
[TBL] [Abstract][Full Text] [Related]
17. Oxytocin's neurochemical effects in the medial prefrontal cortex underlie recovery of task-specific brain activity in autism: a randomized controlled trial.
Aoki Y; Watanabe T; Abe O; Kuwabara H; Yahata N; Takano Y; Iwashiro N; Natsubori T; Takao H; Kawakubo Y; Kasai K; Yamasue H
Mol Psychiatry; 2015 Apr; 20(4):447-53. PubMed ID: 25070538
[TBL] [Abstract][Full Text] [Related]
18. Association between the oxytocin receptor (OXTR) gene and autism: relationship to Vineland Adaptive Behavior Scales and cognition.
Lerer E; Levi S; Salomon S; Darvasi A; Yirmiya N; Ebstein RP
Mol Psychiatry; 2008 Oct; 13(10):980-8. PubMed ID: 17893705
[TBL] [Abstract][Full Text] [Related]
19. Intranasal Oxytocin to Prevent Posttraumatic Stress Disorder Symptoms: A Randomized Controlled Trial in Emergency Department Patients.
van Zuiden M; Frijling JL; Nawijn L; Koch SBJ; Goslings JC; Luitse JS; Biesheuvel TH; Honig A; Veltman DJ; Olff M
Biol Psychiatry; 2017 Jun; 81(12):1030-1040. PubMed ID: 28087128
[TBL] [Abstract][Full Text] [Related]
20. Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder.
Sikich L; Kolevzon A; King BH; McDougle CJ; Sanders KB; Kim SJ; Spanos M; Chandrasekhar T; Trelles MDP; Rockhill CM; Palumbo ML; Witters Cundiff A; Montgomery A; Siper P; Minjarez M; Nowinski LA; Marler S; Shuffrey LC; Alderman C; Weissman J; Zappone B; Mullett JE; Crosson H; Hong N; Siecinski SK; Giamberardino SN; Luo S; She L; Bhapkar M; Dean R; Scheer A; Johnson JL; Gregory SG; Veenstra-VanderWeele J
N Engl J Med; 2021 Oct; 385(16):1462-1473. PubMed ID: 34644471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
